Table 1.
Valproate | No. scanning runs |
No. male |
No. female |
Ages at scanning | Age at onset | Duration | No. AEDs at scanning |
No. previously failed AEDs |
---|---|---|---|---|---|---|---|---|
Resistant | 14 | 3 | 6 | 29.6 ± 15.1 | 11 ± 7.1 | 18.6 ± 19.2 | 2.3 ± 1.0 | 3.9 ± 2.1 |
Responsive | 12 | 8 | 2 | 29.6 ± 11.6 | 18.5 ± 14.7 | 11.1 ± 5.6 | 1.7 ± 0.5 | 2.7 ± 2.2 |
Unknown | 11 | 3 | 3 | 27.5 ± 9.0 | 18.8 ± 7.7 | 8.3 ± 8.5 | 1.3 ± 0.5 | 0.8 ± 0.8 |
Number of scanning runs and number of male and female subjects is provided along with mean ± SD of age at scanning age at disease onset, disease duration (years), number of antiepileptic drugs (AEDs) at time of scanning and number of previously failed AEDs